Selection for growth and income: Abbott Labs (ABT - 43.10)
Article Abstract:
A profile of Abbott Laboratories, United States based global leader in medical supplies manufacturing company, is furnished. Analysis of stock prices of Abbot Labs is done based on the information as of February 10, 2006. The stocks of the company are expected to register good income as well as growth in a 3 to 5 years time frame.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Abbott Labs
Article Abstract:
The article provides the price appreciation potential of the shares of Abbott Laboratories for the years 2010-2012. The Abbott Park, Illinois-based company offers adult and pediatric pharmaceuticals, diagnostic systems, nutritional products and vascular products.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Abbott Labs
Article Abstract:
The price appreciation potential of the shares of Abbott Laboratories for the years 2010-2012 is discussed. The Abbott Park, Illinois-based company manufactures pharmaceuticals, disgnostic equipment, nutritional products, and vascular products.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Selection for growth and income: Alberto-Culver (ACV-43.83). Toiletries/cosmetics industry
- Abstracts: Selection for growth: Bed Bath & Beyond (BBBY - 41.51). Avnet. Selection for growth: Avnet, Inc. (AVT - 25.06)
- Abstracts: Stock highlight: Yellow Roadway (YELL u 50.54). Selection for growth & income: Canadian Nat'l (CNI--49.65). Stock highlight: CSX Corp. (CSX - 48.16)
- Abstracts: OXO's favorite mistakes. A prescription for innovation. Hoop schemes
- Abstracts: Long term incentive plans, executive pay and UK company performance